Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.38 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.38 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27341540 | 0.95 | CA12 (0.39) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL25624631 | 0.94 | MCL1 (0.39) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL25624653 | 0.94 | MCL1 (0.39) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL24090051 | 0.93 | ENPP1 (0.42) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL25624630 | 0.92 | MCL1 (0.39) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL26404380 | 0.92 | PLA2G2A (0.40) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL22063385 | 0.92 | TDP1 (0.38) | CA12CA1CA2CA9MCL1 | |
| SCHEMBL22062617 | 0.92 | TDP1 (0.38) | MCL1ACMSDALOX5TDP1L3MBTL1 | |
| SCHEMBL22547062 | 0.91 | TDP1 (0.40) | ALOX5BACE1TDP1L3MBTL1PLA2G2A | |
| SCHEMBL22541911 | 0.91 | TDP1 (0.40) | ALOX5BACE1TDP1L3MBTL1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11665962-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-05-30 | — | — | US | disclosed |
| US-11665962-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-05-30 | — | — | US | disclosed |
| US-20210384445-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-12-09 | — | — | US | disclosed |
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20200212315-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-07-02 | — | — | US | disclosed |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
| US-20200181160-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | CA12 962/4885CA1 2506/4885CA2 876/4885 |
| US-20200212315-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE, AND COMPOUND | OR10J3, ESR1, NFE2L2 | CA12 893/4885CA1 2114/4885CA2 1869/4885 |
| US-20200181160-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | AHR, EMC2, NFE2L2 | CA12 2017/4885CA1 3799/4885CA2 2369/4885 |
| US-20210384445-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | ESR1, EML4, L1CAM | CA12 1642/4885CA1 2363/4885CA2 2796/4885 |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EMC2, NFE2L2, AOC2 | CA12 1511/4885CA1 3331/4885CA2 1915/4885 |
| US-11665962-B2 | Organic electroluminescence element and electronic device | ESR1, EML4, L1CAM | CA12 1642/4885CA1 2363/4885CA2 2796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.